p-value is a full-service medical communications company that was founded in 2004. Certified by the Women’s Business Enterprise National Council, the company is owned and operated by Linda Corvari, PharmD. Braced with in-house scientific and account management teams, we are the “right-sized” business, balanced to provide the services of a large organization while executing with the agility, attention to detail, and efficiency of a boutique firm. Our team is composed of marketing professionals who have a depth of experience in the biopharmaceutical industry, along with advanced-degree scientific experts with backgrounds in industry, medical communications, and academia. Our focus is on supporting our clients with strategic thinking and delivering programs that achieve brand objectives. Our longstanding partnerships with pharmaceutical and biotech companies, from start-up innovators to recognized industry leaders, validate our success. Let us give you a significantly different experience in medical communications. Find out what our wealth of creative talent, clinical knowledge, and promotional strategizing can do for your brand, from prelaunch market development to loss of exclusivity and beyond. Why p-value? • Significant difference in service, strategy, and execution quality • Unique balance of resources and operations engineered to execute with agility • High-quality content development and flawless execution, exceeding client expectations • Multidisciplinary professionals with depth of experience • Passionate about what we do and about our reputation
Looking for a particular p-value communications employee's phone or email?
The p-value communications annual revenue was $15 million in 2026.
Patrick Defeo is the President and Chief Financial Officer of p-value communications.
177 people are employed at p-value communications.
p-value communications is based in Cedar Knolls, New Jersey.
The NAICS codes for p-value communications are [5416, 54, 541, 54161, 541613].
The SIC codes for p-value communications are [87, 874].